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Abstract Astrocytes synthesize a series of peptides called en- 
dozepines which act as endogenous ligands of benzodiazepine 
receptors. The present study demonstrates that the endozepine 
ODN causes a dose-dependent increase in inositoi trisphosphate 
and a parallel decrease in phosphatidylinositoi bisphosphate in 
cultured rat astrocytes. Pre-incubation of astrocytes with the 
phospholipase C inhibitor U 73122 or with pertussis toxin totally 
blocked polyphosphoinositide metabolism. These data show that, 
in rat astrocytes, ODN stimulates a phospholipase C coupled to 
a pertussis toxin-sensitive G protein. 
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1. Introduction 
The term endozepines designates a novel family of regulatory 
peptides that have been isolated as a result of their ability to 
displace benzodiazepine (BZD) binding from their receptors 
[1-3]. All endozepines derive from an 86 amino acid precursor 
polypeptide called diazepam-binding inhibitor (DBI) which 
generates, through proteolytic leavage, several biologically ac- 
tive fragments, including the tr iakontatetraneuropeptide 
DBI[17-50] (TTN), the octadecaneuropeptide DBI[33 50] 
(ODN) and the tr iakontaseptaneuropeptide DBI[39 75] [4-6]. 
Endozepines are widely distributed in the central nervous 
system and in peripheral organs [7,8]. In the rat brain, endo- 
zepines are primarily synthesized in glial cells [9,10] and 
ODN has been shown to inhibit [3H]diazepam binding in 
cultured rat astrocytes [11], suggesting that endozepines may 
act as paracrine and/or autocrine factors in astroglial 
cells. 
There is now clear evidence that glial cells express a large 
variety of receptors for neuropeptides, which are functionally 
coupled to second messenger systems [12,13]. We have recently 
found that ODN stimulates calcium mobil ization in rat astro- 
cytes [14]. This observation led us to investigate the possible 
effect of endozepines on polyphosphoinosit ide metabolism. 
*Corresponding author. Fax: (33) 35 14 69 46. 
Abbreviations." DBI, diazepam-binding inhibitor; ODN, octadecaneu- 
ropeptide; PTX, pertussis toxin; TTN, triakontatetraneuropeptide. 
2. Materials and methods 
2.1. Chemicals 
Dulbecco's modified Eagle's medium (DMEM) and the antibiotic- 
antimytotic solution were purchased from Gibco. F12 culture medium 
was from Biowhittaker. Fetal calf serum was obtained from Biosys. 
Synthetic ODN was from Bachem. Myo-[3H]inositol was provided by 
Amersham. The phospholipase C inhibitor U 73122 was from Tebu. 
Pertussis toxin (PTX) and all other reagents were purchased from 
Sigma. 
2.2. Cell culture 
Primary cultures of astrocytes were prepared from the brain of Wis- 
tar rats as previously described [15]. Briefly, cerebral hemispheres from 
newborn rats were collected in DMEM/F12 (2: 1; v/v) culture medium 
supplemented with 2 mM glutamine, 1% insulin, 5 mM HEPES (N-2- 
hydroxyethylpiperazine-N'-2-ethane sulfonic acid), 0.4% glucose and 
1% of the antibiotic-antimytotic solution. The tissues were disaggre- 
gated mechanically and filtered through a 82-pro nylon sieve (Tripette 
and Renaud, France). Dissociated cells were resuspended in culture 
medium supplemented with 10% fetal calf serum and seeded in 35-mm 
dishes (Dutscher) at a density of 10 6 cells/dish. The cells were incubated 
at 37°C in a humid atmosphere (5% COz) and the medium was changed 
twice a week. 
2.3. Reverse-phase HPLC analysis 
Cultured astrocytes were incubated with 10 -8 M synthetic ODN for 
30 min. The culture medium was collected and analyzed by high-per- 
formance liquid chromatography (HPLC) on a (250 × 4.6 mm) Lichro- 
sorb C18 column (Alltech) equilibrated with acetonitrile/water/tri- 
fluoroacetic acid (20 : 79.9 : 0.1; v/v/v; pH 2.3) at a flow rate of 1 ml/min. 
The concentration f acetonitrile in the eluting solvent was held for 10 
min at 20% and raised to 60% over 60 min using a linear gradient. 
One-ml fractions were collected and evaporated in a Speed-Vac concen- 
trator (Savant). The concentration of ODN was measured in each 
fraction by radioimmunoassay as previously described [16]. 
2.4. Measurement of polyphosphoinositide metabolism 
Astrocytes were incubated with 10 pCi/ml myo-[3H]inositol (100 Ci/ 
mmol) at 37°C in glucose-free culture medium. For incorporation stud- 
ies, ODN (10 -8 M) was added to the incubation medium for 0-30 min 
and 3H-labeled inositol phosphates were analyzed as previously de- 
scribed [17]. For equilibrium studies, astrocytes were prelabeled with 
[3H]inositol at 37°C for 24 h. Then the cells were washed five times with 
DMEM supplemented with 1 mmol inositol/l and preincubated with 10 
mM LiCI for 10 min. Astrocytes were incubated either with a single 
dose of ODN (10 -8 M) for various durations (30 s-2 min) or with 
various doses of ODN (10-J°-10 -7 M) for 1 min. In one set of experi- 
ments, astrocytes were preincubated with U 73122 (10 -5 M) alone for 
10 min and then with U 73122 plus ODN (10 -8 M) for 1 min. In another 
set of experiments, astrocytes were preincubated with PTX (0.2/zg/ml) 
for 4 h and then with PTX plus ODN (10 -s M) for 1 rain. In all 
experiments the incubations were stopped by removing the medium and 
adding ice-cold 10% trichloroacetic acid for 30 min at 4°C. The cells 
were then homogenized and the homogenate was centrifuged. Inositol 
phosphates contained in the supernatant were analyzed by ion-ex- 
change chromatography, and polyphosphoinositides contained in the 
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pellet were separated by thin layer chromatography as previously de- 
scribed [17]. 
3. Results 
3.1. Effect of ODN on FH]inositol incorporation into 
phospholipids 
Exposure of astrocytes to ODN (10 -8 M) increased the rate 
of incorporation of [3H]inositol into the phospholipid fraction 
(Fig. 1). The effect of ODN was maximum after 15 min and 
vanished within 30 min. HPLC analysis of ODN after a 30-min 
incubation with astrocytes revealed that the peptide was not 
degraded (Fig. 2) and that 90% of authentic ODN was still 
present in the culture medium at the end of the incubation 
period. 
3.2. Effect of  ODN on polyphosphoinositide m tabolism 
The time-course of the effect of ODN on the formation of 
inositol phosphates and the concentration f phosphoinositides 
was studied in [3H]inositol-labeled astrocytes. Administration 
of ODN (10 -8 M) caused a rapid and transient increase in IP 2 
and IP3 formation (Fig. 3A,B) and a concomitant decrease in 
PIP and PIP2 concentrations (Fig. 3C,D). The response to 
ODN reached a maximum after 1 min and the concentrations 
of inositolphosphates and phosphoinositides r turned to basal 
levels within 2 min. 
The effects of graded oses of ODN on polyphosphoinositide 
metabolism are shown in Fig. 4. For concentrations ranging 
from 10 9 to 10 -8 M, ODN induced a dose-related increase in 
IP 2 and IP 3 formation (Fig. 4A,B) and a symmetrical decrease 
of PIP and PIP2 concentrations (Fig. 4C,D). At higher concen- 
trations (3 × 10 -8 and 10 _7 M), the effect of ODN on IP2 and 
IP3 formation gradually disappeared (Fig. 4A,B). 
3.3. Involvement of phospholipase C in the mechanism of action 
of ODN 
Incubation of astrocytes for 10 min with the phospholipase 
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Fig. 1. Time-course of the effect of ODN (10 -8 M) on [3H]inositol 
incorporation i to phosphoinositols in astrocytes. Cells were incubated 
with [~H]inositol in the absence (o) or presence (o) of ODN for the times 
indicated. Each point represents the mean + S.E.M. of four independ- 
ent determinations. *P < 0.05, **P < 0.01, compared with the respec- 
tive control. 
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Fig. 2. Reverse-phase HPLC analysis of synthetic ODN after a 30-min 
incubation with cultured astrocytes at 37°C. All fractions collected 
(1 ml each) were dried and assayed for ODN-like immunoreactivity 
(ODN-LI). The arrows indicate the elution position of synthetic ODN 
and its C-terminal octapeptide (ON). The broken line shows the con- 
centration of acetonitrile inthe eluting solvent. 
C inhibitor U 73122 (10 -5 M) did not affect the basal evel of 
IP 3 and PIP2, but totally blocked the effect of ODN (10 -8 M) 
on IP 3 formation (Fig. 5A) and PIP2 breakdown (Fig. 5B). 
Similarly, incubation of the cells with PTX (0.2 pg/ml) for 4 h 
had no effect on the basal concentration f IP3 and PIP2, but 
totally suppressed the action of ODN on IP3 formation (Fig. 
5A) and PIP2 breakdown (Fig. 5B). 
4. D iscuss ion  
Although endozepines are extremely abundant and widely 
distributed inthe central nervous ystem [7,8], the effect of these 
neuropeptides on second messenger systems have never been 
investigated in glial cells. The present study demonstrates that 
nanomolar concentrations of ODN stimulate polyphospho- 
inositide metabolism in cultured rat astrocytes. First, ODN 
increased the rate of incorporation of[3H]inositol into the mem- 
brane lipid fraction. Second, ODN stimulated inositol phos- 
phate formation and phosphatidylinositol metabolism in glial 
cells. The effect of ODN on [3H]inositol incorporation only 
occurred uring the first 20 min and disappeared after longer 
periods of incubation. HPLC analysis howed that the ODN 
molecule was still intact after a 30-min incubation with astro- 
cytes, indicating that the disappearance of the effect of ODN 
could not be ascribed to degradation of the neuropeptide by 
astroglial cells. These data suggest that the action of ODN on 
astrocytes i associated with a rapid desensitization process. 
Consistent with this hypothesis, we have recently observed that 
repeated pulses of ODN induce an increase in cytosolic alcium 
concentrations i  rat astrocytes, with gradual attenuation f the 
response (Lamacz et al., unpublished data). 
It is now established that glial cells possess a large array of 
receptors for classical neurotransmitters and neuropeptides 
(see [18] for review), most of which are coupled to phospholip- 
ase C. The effect of ODN on inositol phosphate formation and 
phosphatidylinositol breakdown suggests that the action of en- 
dozepines on astroglial cells is mediated by a membrane r cep- 
tor coupled to a phospholipase C. In support of this notion, the 
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Fig. 3. Time-course of the effect of ODN (10 -8 M) on polyphosphoinositide metabolism in cultured astrocytes. (A) Inositol bisphosphate (IP2); 
(B) inositol trisphosphate (IP3); (C) phosphatidylinositol m nophosphate (PIP); (D) phosphatidylinositol bisphosphate (PIP2). Control values are 
represented by open symbols. Each point represents he mean (+S.E.M.) of four independent determinations. ***P< 0.001, **P < 0.01 and 
*P < 0.05, compared with the respective control. 
present data show that the ODN-evoked stimulation of pol- 
yphosphoinositide m tabolism was totally blocked by U 73122, 
a drug which selectively inhibits phospholipase C-dependent 
processes [19]. We also observed that the effect of ODN on 
phosphatidylinositol turnover was abolished when astrocytes 
were incubated with pertussis toxin, indicating that a PTX- 
sensitive G protein is involved in the mechanism of action of 
endozepines on glial cells. 
The administration of graded concentrations of ODN on 
astrocytes revealed that the dose-response curves exhibited a
bell shape with a maximum effect at a concentration f 10 -8 M. 
In agreement with this finding, we have recently observed that 
nanomolar doses of ODN increase cytosolic alcium while mi- 
cromolar doses do not stimulate calcium mobilization and may 
even reduce intracellular calcium levels (Lamacz et al., unpub- 
lished data). These data suggest hat ODN acts through two 
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types of receptors on rat astrocytes: high affinity receptors 
positively coupled to phospholipase C and low affinity recep- 
tors negatively coupled to phospholipase C. 
In conclusion, the present study has demonstrated that nano- 
molar concentrations of ODN stimulate polyphosphoinositide 
metabolism through a PTX-sensitive G protein. Since rat astro- 
cytes synthesize and release substantial amounts of ODN-re- 
lated peptides [8 10], these data support he view that endozep- 
ines may be involved in paracrine and/or autocrine communica- 
tion in astroglial cells. 
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